The correct answer is D, “Study,” as this is the step in the Shewhart/Deming cycle (commonly known as the Plan-Do-Study-Act [PDSA] cycle) where the results of the interventions are compared with the original goal.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the PDSA cycle is a systematic approach to quality improvement, widely used in infection control programs to test and refine interventions. The cycle consists of four stages: Plan (designing the intervention and setting goals), Do (implementing the intervention on a small scale), Study (analyzing the data and comparing outcomes against the original goal), and Act (standardizing successful changes or adjusting based on findings) (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 – Evaluate the effectiveness of educational programs). The Study phase is critical for assessing whether the intervention achieved the intended reduction in infection rates or other performance metrics, providing evidence to guide the next steps.
Option A (Do) involves the execution of the planned intervention, focusing on implementation rather than evaluation, so it does not include comparing results. Option B (Act) is the final step where successful interventions are implemented on a broader scale or adjustments are made, but it follows the comparison made in the Study phase. Option C (Plan) is the initial stage of setting objectives and designing the intervention, which occurs before any results are available for comparison.
The emphasis on the Study phase aligns with CBIC’s focus on using data to evaluate the effectiveness of infection prevention strategies, ensuring that performance improvement projects are evidence-based and goal- oriented (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions). This step enables the infection preventionist to determine if the original goal-such as reducing healthcare-associated infections-was met, facilitating continuous improvement.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions; Domain IV:
Education and Research, Competency 4.2 – Evaluate the effectiveness of educational programs.

A patient with active shingles (herpes zoster) is contagious to individuals who have never had varicella (chickenpox) or the varicella vaccine. The best roommate selection is someone who has received the varicella vaccine, as they are considered immune and not at risk for contracting the virus.
Why the Other Options Are Incorrect?
* B. Treatment with acyclovir – Acyclovir treats herpes zoster but does not prevent transmission to others.
* C. A history of herpes simplex – Prior herpes simplex virus (HSV) infection does not confer immunity to varicella-zoster virus (VZV).
* D. Varicella zoster immunoglobulin (VZIG) – VZIG provides temporary immunity but does not offer long-term protection like the vaccine.
CBIC Infection Control Reference
APIC guidelines recommend placing patients with active shingles in a room with individuals immune to varicella, such as those vaccinated.

Surveillance is a critical tool in infection prevention and control, used to monitor disease trends and guide public health responses. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the “Surveillance and Epidemiologic Investigation” domain, which aligns with the Centers for Disease Control and Prevention (CDC) “Principles of Epidemiology in Public Health Practice” (3rd Edition, 2012).
The question describes a process of collecting and analyzing indicators to signal an increase in community illness, requiring identification of the appropriate surveillance type among the options provided.
Option C, “Syndromic,” is the correct answer. Syndromic surveillance involves monitoring non-specific health indicators or symptoms (e.g., fever, respiratory complaints, or gastrointestinal issues) that may precede a formal diagnosis, aiming to detect potential outbreaks or increases in community illness early. The CDC defines syndromic surveillance as the real-time or near-real-time collection, analysis, and interpretation of health-related data to provide actionable information, often in collaboration with public health agencies. This approach uses data from sources like emergency department visits, over-the-counter medication sales, or absenteeism reports to identify trends before laboratory confirmation, making it well-suited to the described scenario of signaling community illness increases.
Option A, “Passive,” involves healthcare providers or laboratories reporting cases to public health authorities on a voluntary or mandatory basis without active prompting (e.g., routine notifiable disease reporting). While passive surveillance contributes to baseline data, it is less proactive and not specifically designed to signal early increases in illness, making it less fitting. Option B, “Active,” entails public health officials actively seeking data from healthcare facilities or providers (e.g., calling to confirm cases during an outbreak). This is more resource-intensive and typically used for specific investigations rather than ongoing community trend monitoring, which aligns better with syndromic methods. Option D, “Targeted,” refers to surveillance focused on a specific population, disease, or event (e.g., monitoring TB in a high-risk group). The scenario’s broad focus on community illness indicators does not suggest a targeted approach.
The CBIC Practice Analysis (2022) and CDC guidelines highlight syndromic surveillance as a key strategy for early detection of community-wide health threats, often involving collaboration with public health agencies. Option C best matches the described activity of analyzing indicators to signal illness increases, making it the correct choice.
References:
* CBIC Practice Analysis, 2022.
* CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.
* CDC Syndromic Surveillance Systems, 2020.

HIV patients require Airborne Precautions if they have tuberculosis (TB). A cavitary lesion in the upper lobe is highly suggestive of active pulmonary TB, which requires Airborne Precautions due to aerosolized transmission.
Why the Other Options Are Incorrect?
* A. 24-year-old male newly diagnosed with a CD4 count of 70 – Low CD4 count alone does not warrant Airborne Precautions unless there is active TB or another airborne pathogen.
* B. 28-year-old female with Mycobacterium avium in sputum – Mycobacterium avium complex (MAC) is not airborne, and standard precautions are sufficient.
* C. 36-year-old male with cryptococcal meningitis – Cryptococcus neoformans is not transmitted via the airborne route, so Airborne Precautions are unnecessary.
CBIC Infection Control Reference
Patients with HIV and suspected TB require Airborne Precautions until TB is ruled out.

The infectiousness of tuberculosis (TB) is directly related to the number of Mycobacterium tuberculosis organisms expelled into the air by an infected patient.
Step-by-Step Justification:
* TB Transmission Mechanism:
* TB spreads through airborne droplet nuclei, which remain suspended for long periods.
* Factors Affecting Infectiousness:
* High bacterial load in sputum: Smear-positive patients are much more infectious.
* Coughing and sneezing frequency: More expelled droplets increase exposure risk.
* Environmental factors: Poor ventilation increases transmission.
Why Other Options Are Incorrect:
* A. Hand hygiene habits: TB is airborne, not transmitted via hands.
* B. Presence of acid-fast bacilli (AFB) in blood: TB is not typically hematogenous, and blood AFB does not correlate with infectiousness.
* C. Tuberculin skin test (TST) >20 mm: TST indicates prior exposure, not infectiousness.
CBIC Infection Control References:
* APIC Text, “Tuberculosis Transmission and Control Measures”.

The correct answer is D, “staff education related to loaner instrument reprocessing has occurred,” as this is the infection prevention process that should be ensured when a surgeon is beginning a new procedure requiring loaner instruments within the next two weeks. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, loaner instruments-those borrowed from external sources for temporary use-pose unique infection prevention challenges due to potential variability in reprocessing standards and unfamiliarity among staff. Ensuring that staff are educated on proper reprocessing protocols (e.g., cleaning, sterilization, and handling per manufacturer instructions and AAMI ST79) is critical to prevent healthcare- associated infections (HAIs) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). This education should cover the specific requirements for loaner instruments, including documentation and verification of sterilization, and should occur proactively before the instruments are used to ensure competency and compliance.
Option A (items arrive in time for immediate use steam sterilization) is a logistical consideration, but it does not address the infection prevention process itself; timely arrival is necessary but insufficient without proper reprocessing validation. Option B (instruments are able to be used prior to the biological indicator results) is unsafe, as biological indicators are essential to confirm sterilization efficacy, and using instruments before results are available violates infection control standards. Option C (the planning process takes place after the instruments have arrived) is impractical, as planning (e.g., coordinating with vendors, assessing reprocessing needs) must occur in advance to ensure readiness and safety, not as a reactive step.
The focus on staff education aligns with CBIC’s emphasis on preparing healthcare personnel to handle loaner instruments safely, reducing the risk of contamination and ensuring patient safety (CBIC Practice Analysis,
2022, Domain IV: Education and Research, Competency 4.1 – Develop and implement educational programs).
This proactive measure is supported by AAMI and CDC guidelines, which stress the importance of training for reprocessing complex or unfamiliar devices.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment; Domain IV: Education and Research, Competency 4.1 – Develop and implement educational programs. AAMI ST79:2017, Comprehensive guide to steam sterilization and sterility assurance in health care facilities.

A safety culture withreciprocal accountabilityemphasizes mutual responsibility for maintaining safe practices, encouraging staff at all levels to “speak up” or “stop the line” when they observe risky practices.
This concept reflects a learning organization and a just culture that supports open communication and proactive risk mitigation.
* According to theAPIC Text, a strong safety culture is described as one where:
“The leadership can expect staff members to call out or stop the line when they see risk, and staff can expect leadership to listen and act.” This dynamic reflects reciprocal accountability.
* Other options are less accurate:
* A. Human factorsrefer to system design, not behavioral accountability.
* B. Honest disclosure of a safety eventis about post-event transparency, not real-time intervention.
* C. A blaming and shaming cultureis antithetical to safety culture principles.
References:
APIC Text, 4th Edition, Chapter 18 – Patient Safety

The correct answer is B, “Review microbiology laboratory reports for enteric organisms in the past week,” as this is the first action the infection preventionist (IP) should perform following the alert of a sewer main break and potential contamination of the city water supply. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, a rapid assessment of existing data is a critical initial step in investigating a potential waterborne outbreak. Reviewing microbiology laboratory reports for enteric organisms (e.g., Escherichia coli, Salmonella, or Shigella) helps the IP identify any recent spikes in infections that could indicate water supply contamination, providing an evidence-based starting point for the investigation (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.2 – Analyze surveillance data). This step leverages available hospital data to assess the scope and urgency of the situation before initiating broader actions.
Option A (notify the Emergency and Admissions departments to report diarrhea cases to infection control) is an important subsequent step to enhance surveillance, but it relies on proactive reporting and does not provide immediate evidence of an ongoing issue. Option C (contact the Employee Health department and ask for collaboration in case-finding) is valuable for involving additional resources, but it should follow the initial data review to prioritize case-finding efforts based on identified trends. Option D (review the emergency preparedness plan with engineering for sources of potable water) is a critical preparedness action, but it is more relevant once contamination is confirmed or as a preventive measure, not as the first step in assessing the current situation.
The focus on reviewing laboratory reports aligns with CBIC’s emphasis on using surveillance data to guide infection prevention responses, enabling the IP to quickly determine if the sewer main break has already impacted patient health and to escalate actions accordingly (CBIC Practice Analysis, 2022, Domain II:
Surveillance and Epidemiologic Investigation, Competency 2.1 – Conduct surveillance for healthcare- associated infections and epidemiologically significant organisms). This approach is consistent with CDC guidelines for responding to waterborne outbreak alerts (CDC Environmental Public Health Guidelines, 2020).
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.1 – Conduct surveillance for healthcare-associated infections and epidemiologically significant organisms, 2.2 – Analyze surveillance data. CDC Environmental Public Health Guidelines, 2020.

The correct answer is C, “the device manufacturer’s written instructions for use,” as this is the factor that determines the appropriate cleaning and disinfection process for a particular surgical instrument. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of surgical instruments must follow the specific instructions provided by the device manufacturer to ensure safety and efficacy. These instructions account for the instrument’s material, design, and intended use, specifying the appropriate cleaning agents, disinfection methods, sterilization techniques, and contact times to prevent damage and ensure the elimination of pathogens (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). This is also mandated by regulatory standards, such as those from the Food and Drug Administration (FDA) and the Association for the Advancement of Medical Instrumentation (AAMI), which require adherence to manufacturer guidelines to maintain device integrity and patient safety.
Option A (all surgical instruments are cleaned and sterilized in the same manner) is incorrect because different instruments have unique characteristics (e.g., materials like stainless steel vs. delicate optics), necessitating tailored reprocessing methods rather than a one-size-fits-all approach. Option B (instruments contaminated with blood must be bleach cleaned first) is a misconception; while blood contamination requires thorough cleaning, bleach is not universally appropriate and may damage certain instruments unless specified by the manufacturer. Option D (the policies of the sterile processing department) may guide internal procedures but must be based on and subordinate to the manufacturer’s instructions to ensure compliance and effectiveness.
The emphasis on manufacturer instructions aligns with CBIC’s focus on evidence-based reprocessing practices to prevent healthcare-associated infections (HAIs) and protect patients (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.5 – Evaluate the environment for infection risks). Deviating from these guidelines can lead to inadequate sterilization or instrument damage, increasing infection risks.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 – Ensure safe reprocessing of medical equipment, 3.5 – Evaluate the environment for infection risks. AAMI ST79:2017, Comprehensive guide to steam sterilization and sterility assurance in health care facilities.

Surveillance is a critical tool in infection prevention and control, used to monitor disease trends and guide public health responses. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the “Surveillance and Epidemiologic Investigation” domain, which aligns withthe Centers for Disease Control and Prevention (CDC) “Principles of Epidemiology in Public Health Practice” (3rd Edition, 2012). The question describes a process of collecting and analyzing indicators to signal an increase in community illness, requiring identification of the appropriate surveillance type among the options provided.
Option C, “Syndromic,” is the correct answer. Syndromic surveillance involves monitoring non-specific health indicators or symptoms (e.g., fever, respiratory complaints, or gastrointestinal issues) that may precede a formal diagnosis, aiming to detect potential outbreaks or increases in community illness early. The CDC defines syndromic surveillance as the real-time or near-real-time collection, analysis, and interpretation of health-related data to provide actionable information, often in collaboration with public health agencies. This approach uses data from sources like emergency department visits, over-the-counter medication sales, or absenteeism reports to identify trends before laboratory confirmation, making it well-suited to the described scenario of signaling community illness increases.
Option A, “Passive,” involves healthcare providers or laboratories reporting cases to public health authorities on a voluntary or mandatory basis without active prompting (e.g., routine notifiable disease reporting). While passive surveillance contributes to baseline data, it is less proactive and not specifically designed to signal early increases in illness, making it less fitting. Option B, “Active,” entails public health officials actively seeking data from healthcare facilities or providers (e.g., calling to confirm cases during an outbreak). This is more resource-intensive and typically used for specific investigations rather than ongoing community trend monitoring, which aligns better with syndromic methods. Option D, “Targeted,” refers to surveillance focused on a specific population, disease, or event (e.g., monitoring TB in a high-risk group). The scenario’s broad focus on community illness indicators does not suggest a targeted approach.
The CBIC Practice Analysis (2022) and CDC guidelines highlight syndromic surveillance as a key strategy for early detection of community-wide health threats, often involving collaboration with public health agencies. Option C best matches the described activity of analyzing indicators to signal illness increases, making it the correct choice.
References:
CBIC Practice Analysis, 2022.
CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.
CDC Syndromic Surveillance Systems, 2020.

The correct answer is D, “A monitoring system must be in place following implementation of interventions,” as this is essential to the quality improvement (QI) process. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, a key component of any QI initiative, such as studying the incidence of infections in patients with triple lumen catheters, is the continuous evaluation of interventions to assess their effectiveness and ensure sustained improvement. A monitoring system allows the infection preventionist (IP), Cancer Committee, and Intravenous Therapy Department to track infection rates, identify trends, and make data-driven adjustments to infection control practices post-intervention (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions). This step is critical to validate the success of implemented strategies, such as catheter care protocols, and to prevent healthcare-associated infections (HAIs).
Option A (establish subjective criteria for outcome measurement) is not ideal because QI processes rely on objective, measurable outcomes (e.g., infection rates per 1,000 catheter days) rather than subjective criteria to ensure reliability and reproducibility. Option B (recommendations for intervention must be approved by the governing board) is an important step for institutional support and resource allocation, but it is a preparatory action rather than an essential component of the ongoing QI process itself. Option C (study criteria must be approved monthly by the Cancer Committee) suggests an unnecessary administrative burden; while initial approval of study criteria is important, monthly re-approval is not a standard QI requirement unless mandated by specific policies, and it does not directly contribute to the improvement process.
The emphasis on a monitoring system aligns with CBIC’s focus on using surveillance data to guide and refine infection prevention efforts, ensuring that interventions for triple lumen catheter-related infections are effective and adaptable (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 – Use data to guide infection prevention and control strategies). This approach supports a cycle of continuous improvement, which is foundational to reducing catheter-associated bloodstream infections (CABSI) in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.4 – Evaluate the effectiveness of infection prevention and control interventions, 2.5 – Use data to guide infection prevention and control strategies.

The correct answer is C, “Time the surface remains wet,” as this is the most important factor the infection preventionist (IP) should review when selecting a germicidal wipe for controlling Clostridioides difficile infections (CDIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, effective environmental cleaning is a critical component of infection prevention, particularly for pathogens like C. difficile, which forms hardy spores that are resistant to many disinfectants. The efficacy of a germicidal wipe depends on the contact time-the duration the surface must remain wet with the disinfectant to ensure the killing of C. difficile spores. This is specified by the manufacturer and supported by guidelines from the Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA), which emphasize that the disinfectant must remain wet on the surface for the full recommended contact time (typically 1-10 minutes for sporicidal agents) to achieve the desired level of disinfection (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols).
Option A (cost of a case of wipes) is a practical consideration for budgeting but is secondary to efficacy in infection control, especially for a high-priority pathogen like C. difficile. Option B (size of individual wipes) may affect coverage and convenience but does not directly impact the wipe’s ability to eliminate the pathogen. Option D (correct disposal of the wipe) is important for preventing cross-contamination and ensuring compliance with waste management protocols, but it is a procedural step after use and not the primary factor in selecting the wipe.
The IP’s review of contact time aligns with CBIC’s focus on evidence-based practices to prevent healthcare- associated infections (HAIs). For C. difficile, which is a leading cause of HAIs, selecting a wipe with an appropriate sporicidal agent and ensuring adequate wet contact time is essential to disrupt transmission, particularly in outbreak settings (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019). This factor directly influences the wipe’s effectiveness, making it the critical review point for the task force.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols. CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.

For Sarcoptes scabiei (scabies), Contact Precautions should remain in place until 24 hours after effective treatment has been completed. The first-line treatment is 5% permethrin cream, which is applied to the entire body and left on for 8-14 hours before being washed off.
Why the Other Options Are Incorrect?
* A. When the treatment cream is applied – The mite is still present and infectious until treatment has fully taken effect.
* B. When the bed linen is changed – While changing linens is necessary, it does not indicate that the infestation has cleared.
* D. 24 hours after the second treatment – Most cases require only one treatment with permethrin, though severe cases may need a second dose after a week.
CBIC Infection Control Reference
According to APIC guidelines, Contact Precautions can be discontinued 24 hours after effective treatment has been administered.

To determine which water type is suitable for drinking yet may still pose a risk for disease transmission, we need to evaluate each option based on its definition, treatment process, and potential for contamination, aligning with infection control principles as outlined by the Certification Board of Infection Control and Epidemiology (CBIC).
* A. Purified water: Purified water undergoes a rigorous treatment process (e.g., reverse osmosis, distillation, or deionization) to remove impurities, contaminants, and microorganisms. This results in water that is generally safe for drinking and has a very low risk of disease transmission when properly handled and stored. However, if the purification process is compromised or if contamination occurs post-purification (e.g., due to improper storage or distribution), there could be a theoretical risk.
Nonetheless, purified water is not typically considered a primary source of disease transmission under standard conditions.
* B. Grey water: Grey water refers to wastewater generated from domestic activities such as washing dishes, laundry, or bathing, which may contain soap, food particles, and small amounts of organic matter. It is not suitable for drinking due to its potential contamination with pathogens (e.g., bacteria, viruses) and chemicals. Grey water is explicitly excluded from potable water standards and poses a significant risk for disease transmission, making it an unsuitable choice for this question.
* C. Potable water: Potable water is water that meets regulatory standards for human consumption, as defined by organizations like the World Health Organization (WHO) or the U.S. Environmental Protection Agency (EPA). It is treated to remove harmful pathogens and contaminants, making it safe for drinking under normal circumstances. However, despite treatment, potable water can still pose a risk for disease transmission if the distribution system is contaminated (e.g., through biofilms, cross- connections, or inadequate maintenance of pipes). Outbreaks of waterborne diseases like Legionnaires’ disease or gastrointestinal infections have been linked to potable water systems, especially in healthcare settings. This makes potable water the best answer, as it is suitable for drinking yet can still carry a risk under certain conditions.
* D. Distilled water: Distilled water is produced by boiling water and condensing the steam, which removes most impurities, minerals, and microorganisms. It is highly pure and safe for drinking, often used in medical and laboratory settings. Similar to purified water, the risk of disease transmission is extremely low unless contamination occurs after distillation due to improper handling or storage. Like purified water, it is not typically associated with disease transmission risks in standard use.
The key to this question lies in identifying a water type that is both suitable for drinking and has a documented potential for disease transmission. Potable water fits this criterion because, while it is intended for consumption and meets safety standards, it can still be a vector for disease if the water supply or distribution system is compromised. This is particularly relevant in infection control, where maintaining water safety in healthcare facilities is a critical concern addressed by CBIC guidelines.
References:
* CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which highlights the importance of water safety and the risks of contamination in potable water systems.
* CBIC Examination Content Outline, Domain IV: Environment of Care, which includes managing waterborne pathogens (e.g., Legionella) in potable water supplies.

Aprocess measureassesses how well healthcare personnel follow specific procedures known to prevent infection. In the case of CAUTI (Catheter-Associated Urinary Tract Infection), monitoringstaff compliance with proper insertion techniqueis a direct process measure.
* According to theAPIC/JCR Workbook, effective CAUTI prevention involves evaluating compliance with proper catheter insertion and maintenance practices. Monitoring this behavior is a process measure that directly affects outcomes like infection rate reduction.
* TheCBIC Study Guidealso emphasizes usingcompliance with evidence-based insertion techniques as a strategy to measure and improve CAUTI prevention efforts.
* APIC Textnotes that “a process measure focuses on a process or the steps in a process that leads to a specific outcome.” This includes monitoring healthcare staff performance related to proper catheter insertion and care.
* Incorrect answer rationale:
* A. CAUTI rate per 1000 catheter days- This is anoutcome measure, not a process measure.
* B. Standardized Infection Ratio per unit- Also anoutcome/benchmarking metric.
* C. Rate of bloodstream infections secondary to CAUTI- This is anoutcome, not a process.
References:
APIC/JCR Infection Prevention and Control Workbook, 4th Edition, Chapter 12 – CAUTI Assessment APIC Text, 4th Edition, Chapter 17 – Performance Measures CBIC Study Guide, 6th Edition, Core Competency: Surveillance and Epidemiologic Investigation

The correct answer is B, “Competence,” as it defines the essential knowledge, behaviors, and skills that an individual should possess and demonstrate to practice in a specific discipline. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, competence encompasses the integrated application of knowledge, skills, and behaviors required to perform effectively in a professional role, such as infection prevention and control. Competence goes beyond mere knowledge or training by including the ability to apply these attributes in real-world scenarios, ensuring safe and effective practice (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.3 – Assess competence of healthcare personnel). This holistic definition is critical in healthcare settings, where demonstrated competence-through actions like proper hand hygiene or outbreak management-directly impacts patient safety and infection prevention outcomes.
Option A (certification) refers to a formal recognition or credential (e.g., CIC certification) that validates an individual’s qualifications, but it is an outcome or process rather than the definition of the underlying abilities.
Option C (knowledge) represents the theoretical understanding or factual basis of a discipline, which is a component of competence but not the full scope that includes behaviors and skills. Option D (training) involves the education or instruction provided to develop skills and knowledge, serving as a means to achieve competence rather than defining it.
The focus on competence aligns with CBIC’s emphasis on ensuring that healthcare personnel are equipped to meet the demands of infection prevention through a combination of education, practice, and evaluation (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 – Evaluate the effectiveness of educational programs). This definition supports the development of professionals who can adapt and perform effectively in dynamic healthcare environments.
References: CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competencies 4.2 – Evaluate the effectiveness of educational programs, 4.3 – Assess competence of healthcare personnel.

Incidence rate is a fundamental epidemiological measure used to quantify the frequency of new cases of a disease within a specified population over a defined time period. The Certification Board of Infection Control and Epidemiology (CBIC) supports the use of such metrics in the “Surveillance and Epidemiologic Investigation” domain, aligning with the Centers for Disease Control and Prevention (CDC) “Principles of Epidemiology in Public Health Practice” (3rd Edition, 2012). The formula provided, XY×K=Rate\frac{X}
{Y} \times K = RateYX×K=Rate, represents the standard incidence rate calculation, where KKK is a constant (e.g., 1,000 or 100,000) to express the rate per unit population, and the question asks what YYY represents among the given options.
In the incidence rate formula, XXX typically represents the number of new cases (or events) of the disease occurring during a specific period, and YYY represents the population at risk during that same period. The ratio XY\frac{X}{Y}YX yields the rate per unit of population, which is then multiplied by KKK to standardize the rate (e.g., cases per 1,000 persons). The CDC defines the denominator (YYY) as the population at risk, which includes individuals susceptible to the disease over the observation period. Option B (“Number of infected patients”) might suggest XXX if it specified new cases, but as the denominator YYY, it is incorrect because incidence focuses on new cases relative to the at-risk population, not the total number of infected individuals (which could include prevalent cases). Option C (“Population at risk”) correctly aligns with YYY, representing the base population over which the rate is calculated.
Option A, “Population served,” is a broader term that might include the total population under care (e.g., in a healthcare facility), but it is not specific to those at risk for new infections, making it less precise. Option D,
“Number of events,” could align with XXX (new cases or events), but as the denominator YYY, it does not fit the formula’s structure. The CBIC Practice Analysis (2022) and CDC guidelines reinforce that the denominator in incidence rates is the population at risk, ensuring accurate measurement of new disease occurrence.
References:
* CBIC Practice Analysis, 2022.
* CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.

The primary source of organisms causing surgical site infections (SSIs) is the patient’s own endogenous flora. Bacteria from the skin, mucous membranes, or gastrointestinal tract contaminate the surgical site, leading to infection. Common pathogens include Staphylococcus aureus, coagulase-negative staphylococci, and Enterobacteriaceae.
Why the Other Options Are Incorrect?
* A. Operating room environment – While environmental contamination can contribute, it is not the primary source.
* B. Operating room personnel – Infection control measures (hand hygiene, gloves, masks) reduce transmission from personnel.
* D. Healthcare personnel’s hands – Although hand contamination is a risk, it is secondary to the patient’s endogenous flora.
CBIC Infection Control Reference
According to APIC guidelines, the patient’s own flora is the primary source of SSIs.

The selection of an appropriate antiseptic for the insertion of an intravascular device (e.g., peripheral or central venous catheters) is a critical infection prevention measure to reduce the risk of catheter-related bloodstream infections (CRBSIs). The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes evidence-based practices in the “Prevention and Control of Infectious Diseases” domain, which includes adhering to guidelines for aseptic technique during invasive procedures. The Centers for Disease Control and Prevention (CDC) provides specific recommendations for skin antisepsis, as outlined in the
“Guidelines for the Prevention of Intravascular Catheter-Related Infections” (2017).
Option A, chlorhexidine, is the preferred antiseptic for skin preparation prior to intravascular device insertion in adults with no contraindications. Chlorhexidine, particularly in a 2% chlorhexidine gluconate (CHG) with
70% isopropyl alcohol solution, is recommended by the CDC due to its broad-spectrum antimicrobial activity, residual effect (which continues to kill bacteria after application), and superior efficacy compared to other agents in reducing CRBSI rates. Studies cited in the CDC guidelines demonstrate that chlorhexidine-based preparations significantly lower infection rates compared to povidone-iodine or alcohol alone, making it the gold standard for this procedure when tolerated by the patient.
Option B, povidone-iodine, is an alternative antiseptic that can be used for skin preparation. It is effective against a wide range of microorganisms and is often used when chlorhexidine is contraindicated (e.g., in patients with chlorhexidine allergy). However, its efficacy is less persistent than chlorhexidine, and it requires longer drying time, which can be a limitation in busy clinical settings. The CDC considers povidone-iodine a second-line option unless chlorhexidine is unavailable or unsuitable. Option C, alcohol (e.g., 70% isopropyl or ethyl alcohol), has rapid bactericidal activity but lacks a residual effect, making it less effective for prolonged protection during catheter dwell time. It is often used as a component of chlorhexidine-alcohol combinations but is not recommended as a standalone antiseptic for intravascular device insertion. Option D, antibiotic ointment, is not appropriate for skin preparation during insertion. Antibiotic ointments (e.g., bacitracin or mupirocin) are sometimes applied to catheter sites post-insertion to prevent infection, but their use is discouraged by the CDC due to the risk of promoting antibiotic resistance and fungal infections, and they are not classified as antiseptics for initial skin antisepsis.
The CBIC Practice Analysis (2022) supports the adoption of CDC-recommended practices, and the 2017 CDC guidelines explicitly state that chlorhexidine-based preparations with alcohol should be used for skin antisepsis unless contraindicated. For a patient with no contraindications, the infection preventionist should suggest chlorhexidine to optimize patient safety and align with best practices.
References:
* CBIC Practice Analysis, 2022.
* CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2017.